The Incubator in Sahlgrenska Science PArk 2016-2019
| Reference number | |
| Coordinator | Sahlgrenska Science Park AB |
| Funding from Vinnova | SEK 12 000 000 |
| Project duration | January 2016 - February 2021 |
| Status | Completed |
| Venture | 2015-00071-en |
Important results from the project
To develop internationally competitive Life Science companies Fulfillment: The companies focus on specific customer needs More companies have started, developed and grown Companies have more quickly started their international expansion Growth capital and investments in new companies have increased Increased growth in the Health Tech area Innovations have been implemented in the healthcare sector, which has contributed to strengthening efficiency and quality and increased digitalisation. Collaboration with other incubators regionally and nationally has been deepened
Expected long term effects
Number of companies evaluated 338 Companies with one woman in the founding team have increased from 38% to 51% Total number of companies that have received coaching 39 Companies with entrepreneurs who are women have increased from 19% to 30% Total invested capital SEK 425 million Verification funds allocated SEK 4.3 million Companies that started Internationalization activities 44% Companies with established sales International 30% Companies that started International establishments 28% Agenda 2030 and sustainability analysis carried out in 23% of the companies
Approach and implementation
Key to success Customer-focused product development in collaboration with healthcare Verification grants in early development phases Cooperation regionally within VINK, nationally within ALIS and SISP, Nordic within HTN International focus with international contacts and network HealthTech focus with challenges as interoperability, cyber security. Growth capital focus to attract external capital. Internal process with readiness matrix as structure. Business development team with complementary experience and background.